Speakers: Philip Burgess, John Wilding
Ophthalmologist Philip Burgess joins Clinical Diabetologist John Wilding to discuss diabetic retinopathy screening and the key role that it plays in reducing vision loss among people with diabetes (10:00).
Learning points
- The level of risk posed by diabetic retinopathy and the impact that systematic screening has had on outcomes in people with diabetes.
- The challenges associated with administering a systematic retinopathy screening program.
- The current and future role of technological advancements in artificial intelligence.
- The potential benefits and drawbacks to individualizing retinopathy screening intervals on adherence and outcomes.
- Prospective methods of overcoming the obstacles associated with delivering systematic screening in low and middle income countries.
More videos in this series:
- Diabetic retinopathy: Screening.
- Diabetic retinopathy: Pathogenesis.
- Diabetic retinopathy: Treatment.